Cleo-Aron Weiß

Statistics

Publications

Citations

103

H-Index

Active since

2018

Affiliations

University of Regensburg(Current)

Cleo-Aron Weiß is an author at University of Regensburg specializing in programmed death-ligand 1 biomarker, targeted therapy, and programmed cell death ligand 1 inhibition.

Publications per year

2018–2018

Publications

Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab

Markus Eckstein, Philipp Erben, Maximilian C. Kriegmair et al. · European Journal of Cancer · 2018 · 103 citations

Medicine, Oncology, Pharmacology +16

1–1 of 1